{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T21:46:40Z","timestamp":1787867200205,"version":"build-2784847793"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007613","name":"Ankara Universitesi","doi-asserted-by":"publisher","award":["21B0237007"],"award-info":[{"award-number":["21B0237007"]}],"id":[{"id":"10.13039\/100007613","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00210-024-03523-8","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T11:01:46Z","timestamp":1728644506000},"page":"3985-3994","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Synergistic ferroptosis in triple-negative breast cancer cells: Paclitaxel in combination with Erastin induced oxidative stress and Ferroportin-1 modulation in MDA-MB-231 cells"],"prefix":"10.1007","volume":"398","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2809-8946","authenticated-orcid":false,"given":"Filiz","family":"Bakar-Ates","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9461-2339","authenticated-orcid":false,"given":"Erva","family":"Ozkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,11]]},"reference":[{"issue":"5","key":"3523_CR1","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/CAD.0000000000000090","volume":"25","author":"LS Bachegowda","year":"2014","unstructured":"Bachegowda LS, Makower DF, Sparano JA (2014) Taxanes: impact on breast cancer therapy. Anticancer Drugs 25(5):512\u2013521. https:\/\/doi.org\/10.1097\/CAD.0000000000000090","journal-title":"Anticancer Drugs"},{"issue":"4","key":"3523_CR2","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1523\/JNEUROSCI.16-04-01324.1996","volume":"16","author":"V Bindokas","year":"1996","unstructured":"Bindokas V, Jordan J, Lee C, Miller R (1996) Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine. J Neurosci 16(4):1324\u20131336. https:\/\/doi.org\/10.1523\/JNEUROSCI.16-04-01324.1996","journal-title":"J Neurosci"},{"issue":"6","key":"3523_CR3","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.molcel.2020.05.031","volume":"78","author":"J Boshuizen","year":"2020","unstructured":"Boshuizen J, Peeper DS (2020) Rational Cancer Treatment combinations: an Urgent Clinical need. Mol Cell 78(6):1002\u20131018. https:\/\/doi.org\/10.1016\/j.molcel.2020.05.031","journal-title":"Mol Cell"},{"issue":"11\u201312","key":"3523_CR4","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","volume":"73","author":"JY Cao","year":"2016","unstructured":"Cao JY, Dixon SJ (2016) Mechanisms of ferroptosis. Cell Mol Life Sci 73(11\u201312):2195\u20132209. https:\/\/doi.org\/10.1007\/s00018-016-2194-1","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"3523_CR5","first-page":"1935","volume":"62","author":"JG Chen","year":"2002","unstructured":"Chen JG, Horwitz SB (2002) Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs. Cancer Res 62(7):1935\u20131938","journal-title":"Cancer Res"},{"key":"3523_CR6","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41419-023-05930-w","volume":"14","author":"Z Chen","year":"2023","unstructured":"Chen Z, Wang W, Abdul Razak SR et al (2023) Ferroptosis as a potential target for cancer therapy. Cell Death Dis 14:460. https:\/\/doi.org\/10.1038\/s41419-023-05930-w","journal-title":"Cell Death Dis"},{"issue":"7","key":"3523_CR7","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1111\/jog.14779","volume":"47","author":"Q Cheng","year":"2021","unstructured":"Cheng Q, Bao L, Li M, Chang K, Yi X (2021) Erastin synergizes with cisplatin via ferroptosis to inhibit ovarian cancer growth in vitro and in vivo. J Obstet Gynaecol Res 47(7):2481\u20132491. https:\/\/doi.org\/10.1111\/jog.14779","journal-title":"J Obstet Gynaecol Res"},{"key":"3523_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","volume":"22","author":"T-C Chou","year":"1984","unstructured":"Chou T-C, Talalay P (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22:27\u201355. https:\/\/doi.org\/10.1016\/0065-2571(84)90007-4","journal-title":"Adv Enzyme Regul"},{"issue":"1","key":"3523_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1146\/annurev-cancerbio-030518-055844","volume":"3","author":"SJ Dixon","year":"2019","unstructured":"Dixon SJ, Stockwell BR (2019) The Hallmarks of Ferroptosis. Annu Rev Cancer Biol 3(1):35\u201354. https:\/\/doi.org\/10.1146\/annurev-cancerbio-030518-055844","journal-title":"Annu Rev Cancer Biol"},{"issue":"5","key":"3523_CR9","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR et al (2012) Ferroptosis: An Iron-Dependent form of non-apoptotic cell death. Cell 149(5):1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042","journal-title":"Cell"},{"issue":"2","key":"3523_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.5152\/tjbh.2015.1669","volume":"11","author":"N Eliyatkin","year":"2015","unstructured":"Eliyatkin N, Yalcin E, Zengel B, Akta\u015f S, Vardar E (2015) Molecular classification of breast carcinoma: from traditional, old-fashioned way to a New Age, and a New Way. J Breast Heal 11(2):59\u201366. https:\/\/doi.org\/10.5152\/tjbh.2015.1669","journal-title":"J Breast Heal"},{"key":"3523_CR12","doi-asserted-by":"publisher","first-page":"1226044","DOI":"10.3389\/fcell.2023.1226044","volume":"11","author":"HT Endale","year":"2023","unstructured":"Endale HT, Tesfaye W, Mengstie TA (2023) ROS induced lipid peroxidation and their role in ferroptosis. Front Cell Dev Biol 11:1226044. https:\/\/doi.org\/10.3389\/fcell.2023.1226044","journal-title":"Front Cell Dev Biol"},{"key":"3523_CR13","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/B978-0-323-47674-4.00088-8","volume-title":"Abeloff\u2019s Clinical Oncology","author":"NL Henry","year":"2020","unstructured":"Henry NL, Shah PD, Haider I, Freer PE, Jagsi R, Sabel MS (2020) Abeloff\u2019s Clinical Oncology. Elsevier, pp 1560\u20131603. https:\/\/doi.org\/10.1016\/B978-0-323-47674-4.00088-8"},{"issue":"5","key":"3523_CR14","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/CAD.0000000000000056","volume":"25","author":"R Karki","year":"2014","unstructured":"Karki R, Seagle B-LL, Nieves-Neira W, Shahabi S (2014) Taxanes in combination with biologic agents for ovarian and breast cancers. Anticancer Drugs 25(5):536\u2013554. https:\/\/doi.org\/10.1097\/CAD.0000000000000056","journal-title":"Anticancer Drugs"},{"issue":"2","key":"3523_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00404-015-3859-y","volume":"293","author":"P Kumar","year":"2016","unstructured":"Kumar P, Aggarwal R (2016) An overview of triple-negative breast cancer. Arch Gynecol Obstet 293(2):247\u2013269. https:\/\/doi.org\/10.1007\/s00404-015-3859-y","journal-title":"Arch Gynecol Obstet"},{"issue":"12","key":"3523_CR16","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.3390\/antiox11122444","volume":"11","author":"J Lee","year":"2022","unstructured":"Lee J, Roh JL (2022) SLC7A11 as a gateway of metabolic perturbation and ferroptosis vulnerability in Cancer. Antioxid (Basel) 11(12):2444. https:\/\/doi.org\/10.3390\/antiox11122444","journal-title":"Antioxid (Basel)"},{"issue":"7","key":"3523_CR17","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1002\/ijc.28159","volume":"133","author":"C Louandre","year":"2013","unstructured":"Louandre C, Ezzoukhry Z, Godin C, Barbare JC, Mazi\u00e8re JC, Chauffert B, Galmiche A (2013) Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib. Int J Cancer 133(7):1732\u20131742. https:\/\/doi.org\/10.1002\/ijc.28159","journal-title":"Int J Cancer"},{"issue":"6","key":"3523_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/brb3.1312","volume":"9","author":"A Molassiotis","year":"2019","unstructured":"Molassiotis A, Cheng HL, Leung KT et al (2019) Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane\u2010 and platinum\u2010based chemotherapy. Brain Behav 9(6):1\u201310. https:\/\/doi.org\/10.1002\/brb3.1312","journal-title":"Brain Behav"},{"key":"3523_CR19","doi-asserted-by":"publisher","first-page":"121222","DOI":"10.1016\/j.lfs.2022.121222","volume":"312","author":"E Ozkan","year":"2023","unstructured":"Ozkan E, Bakar-Ates F (2023) Etoposide in combination with erastin synergistically altered iron homeostasis and induced ferroptotic cell death through regulating IREB2\/FPN1 expression in estrogen receptor positive-breast cancer cells. Life Sci 312:121222. https:\/\/doi.org\/10.1016\/j.lfs.2022.121222","journal-title":"Life Sci"},{"issue":"1","key":"3523_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-19213-4","volume":"8","author":"M Sato","year":"2018","unstructured":"Sato M, Kusumi R, Hamashima S et al (2018) The ferroptosis inducer erastin irreversibly inhibits system xc- and synergizes with cisplatin to increase cisplatin\u2019s cytotoxicity in cancer cells. Sci Rep 8(1):1\u20139. https:\/\/doi.org\/10.1038\/s41598-018-19213-4","journal-title":"Sci Rep"},{"issue":"2","key":"3523_CR21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/cyto.990130216","volume":"13","author":"I Schmid","year":"1992","unstructured":"Schmid I, Krall WJ, Uittenbogaart CH, Braun J, Giorgi JV (1992) Dead cell discrimination with 7-amino-actinomcin D in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry 13(2):204\u2013208. https:\/\/doi.org\/10.1002\/cyto.990130216","journal-title":"Cytometry"},{"issue":"2","key":"3523_CR22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H et al (2017) Ferroptosis: a regulated cell death Nexus linking metabolism, Redox Biology, and Disease. Cell 171(2):273\u2013285. https:\/\/doi.org\/10.1016\/j.cell.2017.09.021","journal-title":"Cell"},{"issue":"3","key":"3523_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"3523_CR24","doi-asserted-by":"publisher","first-page":"118782","DOI":"10.1016\/j.ijpharm.2019.118782","volume":"572","author":"H Tang","year":"2019","unstructured":"Tang H, Chen D, Li C et al (2019) Dual GSH-exhausting sorafenib loaded manganese-silica nanodrugs for inducing the ferroptosis of hepatocellular carcinoma cells. Int J Pharm 572:118782. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118782","journal-title":"Int J Pharm"},{"issue":"18","key":"3523_CR25","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1091\/mbc.E14-04-0916","volume":"25","author":"BA Weaver","year":"2014","unstructured":"Weaver BA (2014) How Taxol\/paclitaxel kills cancer cells. Mol Biol Cell 25(18):2677\u20132681. https:\/\/doi.org\/10.1091\/mbc.E14-04-0916","journal-title":"Mol Biol Cell"},{"key":"3523_CR26","doi-asserted-by":"publisher","first-page":"20143","DOI":"10.1021\/acsami.4c00558","volume":"16","author":"Y Wen","year":"2024","unstructured":"Wen Y, Li K, Ni M, Jiang H, Wu H, Yu Q, Li J, Li X, Wei J, Wu W, Xu H (2024) Dendritic polylysine with paclitaxel and triptolide codelivery for enhanced Cancer ferroptosis through the Accumulation of ROS. ACS Appl Mater Interfaces 16:20143\u201320156. https:\/\/doi.org\/10.1021\/acsami.4c00558","journal-title":"ACS Appl Mater Interfaces"},{"issue":"3","key":"3523_CR27","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2015.158","volume":"23","author":"Y Xie","year":"2016","unstructured":"Xie Y, Hou W, Song X, Yu Y, Huang J, Sun X, Kang R, Tang D (2016) Ferroptosis: process and function. Cell Death Differ 23(3):369\u2013379. https:\/\/doi.org\/10.1038\/cdd.2015.158","journal-title":"Cell Death Differ"},{"issue":"33","key":"3523_CR28","doi-asserted-by":"publisher","first-page":"17303","DOI":"10.1074\/jbc.M116.721936","volume":"291","author":"I Yanatori","year":"2016","unstructured":"Yanatori I, Richardson DR, Imada K, Kishi F (2016) Iron Export through the Transporter Ferroportin 1 is modulated by the Iron Chaperone PCBP2. J Biol Chem 291(33):17303\u201317318. https:\/\/doi.org\/10.1074\/jbc.M116.721936","journal-title":"J Biol Chem"},{"key":"3523_CR29","doi-asserted-by":"publisher","first-page":"116512","DOI":"10.1016\/j.biopha.2024.116512","volume":"174","author":"W Zhang","year":"2024","unstructured":"Zhang W, Liu Y, Liao Y, Zhu C, Zou Z (2024) GPX4, ferroptosis, and diseases. Biomed Pharmacother 174:116512. https:\/\/doi.org\/10.1016\/j.biopha.2024.116512","journal-title":"Biomed Pharmacother"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03523-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03523-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03523-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T02:02:53Z","timestamp":1744164173000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03523-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,11]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["3523"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03523-8","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,11]]},"assertion":[{"value":"3 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}